Skip to main content

Table 4 Distribution of scores for uptake of continuous care and results of univariable ordinal logistic regression analysis (unadjusted) according to level of composite care score of continuous care

From: Measuring the uptake of continuous care among people living with HIV receiving antiretroviral therapy and social determinants of the uptake of continuous care in the southwest of China: a cross-sectional study

Characteristic Level of composite care (%) p-value Unadjusted ordinal OR (95% CI)
Low (n = 234) Middle (n = 235) High (n = 233)
Age (years)     0.056††  
 18–34 26.9 35.9 41.5   Ref.
 35–49 53.8 43.2 41.5   0.60 (0.44–0.81)**
 50 +  19.2 20.9 17.1   0.69 (0.47–1.02)
Sex     0.016  
 Male 60.3 73.1 74.8   Ref.
 Female 56.9 0.0 34.1   0.60 (0.45–0.81)**
Ethnicity     0.089  
 Han 82.5 82.1 87.2   Ref.
 Other 17.5 17.9 12.8   0.78 (0.54–1.12)
Religious belief     0.305  
 With 14.1 17.1 16.1   Ref.
 Without 85.9 82.9 82.9   0.83 (0.57–1.19)
Marital status     0.522  
 Married 47.0 42.7 43.2   Ref.
 Single 32.1 36.8 37.2   1.22 (0.90–1.65)
 Divorced 17.1 17.9 14.5   1.14 (0.77–1.69)
 Widowed 6.4 2.6 5.1   0.87 (0.43–1.74)
Residence     0.237  
 Rural 9.8 9.8 9.8   Ref.
 Urban 70.9 77.4 75.2   1.06 (0.67–1.69)
 Suburban 19.2 12.8 12.8   0.72 (0.41–1.26)
Employment status      < 0.001  
 Unemployed 58.5 43.2 32.9   Ref.
 Employed 41.5 56.8 67.1   2.20 (1.66–1.80)***
Education level      < 0.001††  
 Primary school or below 29.9 26.5 17.9   Ref.
 Secondary school 44.0 28.6 32.1   1.12 (0.78–1.60)
 High school 13.2 20.5 19.2   1.92 (1.26–2.94)**
 University or equivalent 12.8 24.4 30.8   2.67 (1.79–3.98)***
Medical insurance      < 0.001  
 Uninsured 7.3 9.0 5.6   Ref
 NRCMI 49.6 43.6 39.7   1.05 (0.61–1.80)
 UEBMI 6.4 20.9 26.5   2.89 (1.60–5.26)**
 URBMI 36.8 26.5 28.2   0.99 (0.57–1.72)
SES     0.060††  
 Low 38.5 35.0 25.6   Ref.
 Middle 28.2 33.8 38.0   1.63 (1.17–2.28)**
 High 33.3 30.3 36.3   1.44 (1.03–2.01)*
HIV-acquisition risk      < 0.001  
 PWID 47.4 27.8 23.9   Ref.
 Heterosexuals 35.0 33.8 38.0   1.63 (1.17–2.28)**
 MSM 17.5 38.5 42.7   3.10 (2.20–4.39)***
Chronic comorbidities      < 0.001  
 Yes 51.3 35.9 30.3   Ref.
 No 48.7 64.1 69.7   1.98 (1.49–2.63)***
HIV-related stigma 44.5 (42.0–47.0) 44.0 (41.0–47.0) 44.0 (41.0–47.0) 0.526 0.98 (0.96–1.01)
Social support 1.2 (0.3–2.0) 1.3 (0.8–2.3) 1.2 (0.7–2.0) 0.007 1.12 (1.01–1.23)*
Distance to HIV facility, (km) 10.0 (5.0–30.0) 10.0 (6.0–24.5) 10.0 (5.0–30.0) 0.198 1.00 (0.99–1.00)
Travel time, (hours) 1.0 (0.5–1.0) 0.5 (0.4–1.0) 0.7 (0.5–1.0) 0.405 1.01 (0.93–1.09)
Transportation fee, (yuan) 8.0 (2.0–20.0) 6.0 (2.0–21.5) 6.0 (2.0–20.0) 0.834 1.00 (0.99–1.00)
Waiting time for medicine, (hour) 1.5 (1.0–2.0) 1.0 (0.7–2.0) 1.0 (0.7–2.0) 0.217 0.99 (0.90–1.10)
ART duration, (years) 3.8 (2.2–4.6) 3.7 (2.2–4.7) 3.7 (2.1–4.7) 0.905 0.99 (0.90–1.10)
  1. Data are column percentage or median (IQR). SES socioeconomic status, NRCMI New Rural Cooperative Medical Insurance, UEBMI Urban Employees Basic Medical Insurance, URBMI Urban Residents Basic Medical Insurance, PWID people who inject drugs, MSM men who have sex with men, IDU injecting drug use, Ref. reference group. Kruskal–Wallis test. ††Multinomial Cochran-Armitage trend test. ***, **, *Significant at levels 1, 5 and 10%, respectively